Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Accium BioSciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Accium BioSciences

Accium BioSciences

Seed

Accium BioSciences provides ultra-sensitive bio-analytical services for biotech and pharmaceutical firms in the US.

HQ
Seattle, WA, US
Founded
2004
Overview
Compare
Fundraising
Employees

Accium BioSciences provides accelerator mass spectrometry bio-analytical services to biotechnology and pharmaceutical companies. The company specializes in ultrasensitive quantitation of radio-labeled drugs and their metabolites in clinical samples, enabling precise detection in small biological samples. Based in Seattle, Accium BioSciences focuses on enhancing drug development processes within the United States.

Accium BioSciences has made significant strides in the biotech and pharmaceutical sectors by offering cutting-edge analytical solutions. Their advanced techniques have supported numerous clinical studies, contributing to the development of safer and more effective drugs. The company's impact is evident in its collaborations with leading industry players, driving innovation and improving healthcare outcomes.

Accium BioSciences - Similar Companies

BioAnalytics logo

BioAnalytics

Revolution Biosciences logo

Revolution Biosciences

BioAnalytix logo

BioAnalytix

bioanalytixinc.com

Amador Bioscience logo

Amador Bioscience

Accelevir Diagnostics logo

Accelevir Diagnostics

Attometrics logo

Attometrics

Andson Biotech logo

Andson Biotech

andsonbiotech.com

RedShift BioAnalytics logo

RedShift BioAnalytics

redshiftbio.com

Analiza logo

Analiza

analiza.com

Bioinformatics logo

Bioinformatics

bioinfoinc.com

Protea Biosciences logo

Protea Biosciences

proteabio.com

Amplified Sciences logo

Amplified Sciences

Aibiotech logo

Aibiotech

BioDatomics logo

BioDatomics

biodatomics.com

Aperture Bio logo

Aperture Bio

aperture.bio

Accium BioSciences - Quick Facts

Who are Accium BioSciences' competitors?

Companies similar to Accium BioSciences include BioAnalytics, Revolution Biosciences, BioAnalytix and Amador Bioscience.

When was Accium BioSciences founded?

Accium BioSciences was founded in 2004.

Where is Accium BioSciences' headquarters located?

Accium BioSciences' headquarters is located in Seattle, WA, US.

When was Accium BioSciences' last funding round?

Accium BioSciences' most recent funding round was for $3M (USD) in January 2006.

How much has Accium BioSciences raised to-date?

As of Jan 9, 2006, Accium BioSciences has raised a total of $3M (USD).

How many employees does Accium BioSciences have?

Accium BioSciences has 8 employees as of Feb 5, 2024.

Accium BioSciences - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Bioanalytical Services
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7220Research and experimental development on social sciences and humanities
  • 7320Market research and public opinion polling
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 541720Research and Development in the Social Sciences and Humanities
  • 541910Marketing Research and Public Opinion Polling
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 541900Other Professional, Scientific, and Technical Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8732Commercial Economic, Sociological, And Educational Research
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified